TL;DR
A MedPage Today neurology roundup published Oct. 20 reported three developments: unintentional napping was associated with possible or probable dementia in a study, Nature issued an expression of concern about a 2017 autism paper, and Fred Lorenzen was diagnosed with stage 3 CTE after his death. The reported findings do not establish that napping causes dementia, and the source gives no details about the concerns behind the journal notice.
A study linked unintentional napping with a higher incidence of possible or probable dementia, while the journal Nature issued an expression of concern about a 2017 autism paper and researchers diagnosed late NASCAR Hall of Famer Fred Lorenzen with stage 3 CTE. The developments were reported in a MedPage Today neurology roundup published Oct. 20, 2026; they concern dementia research, the status of a prominent scientific paper, and brain injury in auto racing.
The napping finding came from data in the National Health and Aging Trends Study, according to MedPage Today. The report says unintentional napping was associated with a higher incidence of possible or probable dementia. It does not provide the study’s sample size, length of follow-up, effect size or details about how napping was measured, and an association does not show that napping causes dementia.
Nature issued an editorial expression of concern about a highly cited 2017 paper that proposed that bacteria in a mother’s gut promoted neurodevelopmental abnormalities in mice. The roundup did not state what prompted the notice, whether the paper’s findings have been withdrawn or corrected, or whether the authors responded. An expression of concern flags questions about a paper; the supplied report does not describe a final editorial finding.
The Concussion & CTE Foundation announced that Boston University researchers diagnosed Lorenzen with stage 3 chronic traumatic encephalopathy. Lorenzen, a NASCAR Hall of Famer, died in 2024 at age 89. The announcement described him as the first NASCAR driver with a confirmed CTE diagnosis. The diagnosis was made after his death; the roundup does not provide details of the evaluation or say what role his racing career played in the condition.
Implications for Dementia and Racing
The three developments have different implications, but each highlights limits in how brain health evidence is interpreted. The napping result may help researchers examine sleep behavior as a marker associated with later cognitive outcomes, but it does not show that changing nap habits would prevent dementia. Readers should not treat the finding as a diagnosis or as proof of cause.
The Nature notice matters because the 2017 paper drew substantial attention to a proposed biological link involving maternal gut bacteria and brain development in mice. An editorial concern can affect how researchers and readers assess that work, but the notice alone does not establish that the findings are invalid. The specific basis for the journal’s action remains unreported in the source.
Lorenzen’s diagnosis adds to public discussion of CTE and contact or collision sports. It is a posthumous diagnosis, not evidence that every driver faces the same risk, nor does it establish the contribution of any particular exposure. Its relevance is that a prominent racing figure has been identified with the disease, while the announcement’s available details are limited.
Top picks for "napp dementia risk"
As an affiliate, we earn on qualifying purchases.
Three Separate Neurology Developments
MedPage Today presented these items as part of a broader roundup of neurology and neuroscience news, rather than as one connected study or investigation. The same Oct. 20 report also summarized research on epilepsy and dementia, a U.S. Food and Drug Administration approval announced by UCB for a once-daily autoinjector version of zilucoplan for generalized myasthenia gravis, and other clinical and research developments. Those items provide the roundup’s scope but do not establish a relationship among the napping study, the autism paper and Lorenzen’s diagnosis.
The three central items also rest on different kinds of evidence: a reported statistical association in an aging study, an editorial action by a scientific journal, and a posthumous clinical diagnosis announced by a foundation. Keeping those distinctions clear is necessary when judging what each item does—and does not—show.
“Boston University researchers diagnosed NASCAR Hall of Famer Fred Lorenzen with stage 3 chronic traumatic encephalopathy.”
— Concussion & CTE Foundation, as reported by MedPage Today
Study and Diagnosis Details Missing
The roundup provides no effect size, participant details or follow-up period for the napping result, so readers cannot assess the strength or limits of the association from this account alone. It also does not clarify whether the napping behavior was measured once or repeatedly, or how other health factors were addressed.
For the autism paper, the reason for Nature’s expression of concern, the journal’s next steps and any response from the authors are not given. The notice should not be described as a retraction or as proof that the paper’s conclusions are false based on the information provided.
For Lorenzen, the report does not explain the clinical or tissue evidence behind the stage 3 diagnosis, the criteria used, or the exposures considered. It reports the foundation’s announcement and the description of him as the first NASCAR driver with a confirmed diagnosis, but supplies no wider data about CTE among drivers.
Awaiting Journal and Research Detail
Further information would be needed to interpret the napping finding, including the full study methods, results and limitations. Nature’s editorial notice and any follow-up from the journal or paper’s authors could clarify the basis for the concern and whether the publication’s status changes.
Additional information from the Concussion & CTE Foundation or Boston University researchers could explain Lorenzen’s diagnosis and the evidence supporting it. The source material does not announce a next study, journal decision or follow-up action, so those developments remain unconfirmed.
Key Questions
Does unintentional napping cause dementia?
No causal link is established by the report. It describes an association between unintentional napping and a higher incidence of possible or probable dementia in study data.
What does Nature’s expression of concern mean?
It is an editorial notice indicating concern about a published paper. The roundup does not explain the reason for the notice or report a retraction, correction or final finding.
Who was Fred Lorenzen?
Lorenzen was a NASCAR Hall of Famer who died in 2024 at age 89. The Concussion & CTE Foundation said Boston University researchers diagnosed him posthumously with stage 3 CTE.
Does Lorenzen’s diagnosis show that NASCAR causes CTE?
No. The reported diagnosis concerns one individual. The source does not establish what caused his CTE or provide evidence about the rate of the disease among NASCAR drivers.
Source: rss
